Guthrie Cancer Center

Sayre, Pennsylvania 18840

0 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, Non-Small Cell Lung Cancer, Part 1：r/r B-cell Malignancies, Part 2：B-cell Malignancies

Studies at this site

• A Study of Tyrosine Kinase Inhibitor Orelabrutinib (ICP-022) in Patients With r/r B-Cell Malignancies — Running, not enrolling
• Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET — Completed
• Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer — Completed